wst11

Small moleculeexperimental

Clinical trial activity

8 trials · 13 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
6
Phase 3
0
Phase 4
0

Earliest trial started Sep 1, 2008 (NCT00707356)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • wst11
  • wst 11-mediated vtp therapy

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03617003Phase 1Aug 1, 2018Memorial Sloan-Kettering Cancer Center
NCT03133650Phase 1Apr 26, 2017Cornell University, Steba Biotech S.A., Weizmann Institute of Science
NCT01573156Phase 1/Phase 2 (Phase 2)May 1, 2013Steba Biotech S.A., University of Oxford
NCT00975429Phase 2Sep 1, 2009Frimley Park Hospital NHS Trust, Institut Mutualiste Montsouris, Maastricht University, Steba Biotech S.A., University of Angers, University of London
NCT00974662Phase 2Sep 1, 2009Steba Biotech S.A., University of Versailles
NCT00975039Phase 2Sep 1, 2009Clinique de l'Alma, Steba Biotech S.A.
NCT00946881Phase 1/Phase 2 (Phase 2)Jul 1, 2009New York University, Steba Biotech S.A.
NCT00707356Phase 2Sep 1, 2008Steba Biotech S.A.
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (13)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Steba Biotech S.A.For profit7522008
Clinique de l'AlmaAcademic/Hospital1012009
Cornell UniversityAcademic/Hospital1112017
Frimley Park Hospital NHS TrustAcademic/Hospital1012009
Institut Mutualiste MontsourisAcademic/Hospital1012009
Maastricht UniversityAcademic/Hospital1012009
Memorial Sloan-Kettering Cancer CenterAcademic/Hospital1112018
New York UniversityAcademic/Hospital1012009
University of AngersAcademic/Hospital1012009
University of LondonAcademic/Hospital1012009
University of OxfordAcademic/Hospital1112013
University of VersaillesAcademic/Hospital1012009
Weizmann Institute of ScienceAcademic/Hospital1012017
13 organizations
Page 1 / 1